Rapt Therapeutics, Inc.
RAPT
Revenue
0.00
0.000.00%
3 Months ChangeAssets
127.18M
▼-28.64M▼-18.38%
3 Months ChangeLiabilities
17.96M
▼-7.02M▼-28.11%
3 Months ChangeFree Cash Flow
-27.19M
▼-7.83M▼-40.43%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-093354
2024-08-08
Form 8-K
ID: 0000950170-24-093350
2024-07-19
Form 8-K
ID: 0000950170-24-084991
2024-05-23
Form 8-K
ID: 0000950170-24-064001
2024-05-09
Form 10-Q
ID: 0000950170-24-056302
2024-05-09
Form 8-K
ID: 0000950170-24-056297
2024-03-07
Form 8-K
ID: 0000950170-24-027592
2024-02-22
Form 8-K
ID: 0000950170-24-018920
2024-02-20
Form 8-K
ID: 0000950170-24-017155
2023-11-13
Form 10-Q
ID: 0000950170-23-062471